HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sogole Bahmanyar Selected Research

CC-359

2/2012Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sogole Bahmanyar Research Topics

Disease

1Fibrosis (Cirrhosis)
12/2021
1Idiopathic Pulmonary Fibrosis
12/2021
1Body Weight (Weight, Body)
01/2019
1Triple Negative Breast Neoplasms
11/2017
1Neoplasms (Cancer)
07/2015
1Reperfusion Injury
02/2012

Drug/Important Bio-Agent (IBA)

14- (9- (tetrahydrofuran- 3- yl)- 8- (2,4,6- trifluorophenylamino)- 9H- purin- 2- ylamino)cyclohexanolIBA
12/2021
1CC-90001IBA
12/2021
1Biological ProductsIBA
12/2021
1JNK Mitogen-Activated Protein KinasesIBA
12/2021
1pyrimidineIBA
01/2019
1CDC2 Protein Kinase (Protein p34cdc2)IBA
11/2017
1Phosphotransferases (Kinase)IBA
11/2017
1Mechanistic Target of Rapamycin Complex 2IBA
07/2015
1Mechanistic Target of Rapamycin Complex 1IBA
07/2015
1CC-359IBA
02/2012